期刊文献+

细胞周期蛋白G2在喉癌中的表达 被引量:1

Expression and its significance of Cyclin G2 in laryngeal squamous cell carcinoma
下载PDF
导出
摘要 目的探讨细胞周期蛋白G2(Cyclin G2)的表达与喉鳞状细胞癌的关系。方法收集2000年1月~2000年12月共81例喉鳞状细胞癌患者的临床资料和石蜡块,用免疫组化方法检测肿瘤组织、喉癌旁黏膜Cyclin G2表达:并分析Cyclin G2的表达与喉癌患者年龄、性别、临床分期、肿瘤分化程度以及预后等的关系。统计学分析采用SPSS12.0软件。结果Cyclin G2在喉癌中阳性表达率为67.9%,并随分化程度的降低而降低,有、无淋巴结转移者阳性率分别为38.4%和73.5%,差异均具有显著性(P>0.05)。结论Cyclin G2表达强度与喉癌的恶性程度及发展趋势明显负相关,可作为预测喉癌预后的生物学指标之一。 OBJECTIVE To study the correlation between the expression level of Cyclin G2 and the laryngeal squamous cell carcinoma. METHODS The clinical data and paraffin-embedded tumor samples of 81 patients with LSCC treated at Shenyang 463 Hospital between Jan. 2000 to Dec. 2000 were retrieved. Cyclin G2 expression was analyzed immunohistochemically in tumor tissues and adjacent normal laryngeal mucosa. The relationship between Cyclin G2 expression and clinical data including age, gender, tumor stage, pathological type, and prognosis were analyzed using software SPSS12.0. RESULTS The positive rate of Cyclin G2 in laryngeal squamous cell carcinomas was 66.7 % and it was correlated with tumor differentiation, lymph node metastasis (both P value less than 0.05). CONCLUSION The expression of CyclinG2 correlates with the malignant degree and development tendency of LSCC negatively. Cyclin G2 is an important biological factor affecting the prognosis.
出处 《中国耳鼻咽喉头颈外科》 北大核心 2008年第3期123-125,共3页 Chinese Archives of Otolaryngology-Head and Neck Surgery
关键词 喉肿瘤 鳞状细胞 细胞周期蛋白类 免疫组织化学 Laryngeal Neoplasms Carcinoma, Squamous Cell Cyclins Immunohistochemistry
  • 相关文献

参考文献3

二级参考文献11

  • 1奥斯伯F 金斯顿RE.精编分子生物学实验指南[M].北京:科学出版社,1998.29-108.
  • 2Horne MC, Goolsby GL, Donaldso KL, et al. Cyclin G1 and Cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression. J Biol chem, 1996; 271:6050- 6061.
  • 3Okamoto K, Prives C. A role of Cyclin G in the process of apoptosis.Oncogene, 1999; 18:4606 - 4615.
  • 4Gaiddon C, Moorthy NC, Prives C. Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J, 1999; 18:5609 - 5621.
  • 5Beck J, Handgretinger R, Dopfer R, et al. Expression of mdr1、mrp、 topoisomerase Ⅱ a、β and cyclin A in primary or replased states of atute lymphoblastic leukemias. Br J Haemtol, 1995; 89: 356 -363.
  • 6Sambrook J, Fritsch EF, Maniatis T. Molecular Cloing: a laboratory manual. 2nd ed. New York: Cold Spring Harbor, 1989:18 -24.
  • 7Arber N, Hibshoosh H, Yasui W, et al. Abnommalities in the expression of cell cycle-related proteins in tumors of the small bowel.Cancer Epidemiol Biomarkers Prev, 1999 ;8:1101 - 1105.
  • 8Alevizos I, Mahadevappa M, Zhang X, et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microcarry analysis. Oncogene, 2001; 20:6196-6204.
  • 9Horne MC, Donaldson KL, Goolsby GL, et al. Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest. J Biol Chem, 1997; 272: 12650-12661.
  • 10上海市白血病协作组.急性白血病患者P-gp、mdr1、MRP和TopoⅡ表达及其与预后关系的研究[J].中华血液学杂志,2001,22(2):90-93. 被引量:17

共引文献24

同被引文献12

  • 1贾晋松,徐世荣,马劼,哈森,郭晓楠,王颖.细胞周期蛋白G2 mRNA在急性白血病患者中的表达及临床意义[J].中国实验血液学杂志,2005,13(2):254-259. 被引量:12
  • 2Yue L, Daikoku T, Hou X, et al. Cyelin G1 and eyclin G2 are expressed in the periimplantation mouse uterus in a cell specific and prosvsterone-dependent manner: Evidence for aberrant regulation with Hoxa-10 deficiency[J]. Endocrlnology, 2005,146 ( 5 ) : 2424- 2433.
  • 3Bennin DA,Don AS,Brake T. Cyclin G2 associates with protein phosphatnse 2A catalytic and regulatory B'subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest[J]. J Biol Chem,2002,277(30) :27449-27464.
  • 4Home MC, Goolsby GL, Donaldson KL. Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression[J].J Biol Chore, 1996,271 ( 11 ) : 6050-6061.
  • 5Don AS,Dallapiazza RF, Bennin DA,et al. Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences micmtubule stability and induces a p53-dcpendent cell cycle arrest [J].Exp Cell Res,2006,312(20) :41814204.
  • 6Xu G, Bemaudo S, Fu G, et al. Cyclin G2 is degraded through the ubiquifin-proteasome pathway and mediates the antiprolifemtive effect of acfivin receptor-like kinase 7[J]. Mol Bid Ce11,2008,19 ( 11 ) :4968-4679.
  • 7Stossi F,Likhite VS,Katzenellenbogen JA,etal. Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a reptessor complex at the cyclin G2 promoter[ J]. J Biol Chem,2006, 281 (24) : 16272-16278.
  • 8Martinez-Gac L, Marclues M,Garcia Z,et al. Control of cyclin G2 mRNA expression by forkhead transcription factors:novel mechanism for cell cycle control by phosphoinositide 3-kinase and fork-head [J]. Mol Cell Biol,2004,24-(5) :2181-2189.
  • 9Le XF,Arachchige-Don AS,Mao W,et al. Roles of human epidermal growth factor receptor 2c-jun NH2-terminal kinasephosphoinositide 3-kinaseand p70 $6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells [J]. Mol Cancer Ther, 2007,6( 11 ) :2843-2857.
  • 10Ito Y,Yoshida H,Uruno T, et al. Decreased expression of cyclin G2 is significantly linked to the malignant transformation of papillary carcinoma of the thyroid[J]. Anticancer Res,2003,23(3B) :2335- 2338.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部